Additionally, cancer stem cells expressing CD44+/PrPC+ exhibited a higher liver metastatic capacity compared to CD44+/PrPC- stem cells from CRC, emphasizing the contribution of PrPC to cancer metastasis [62]. This evidence concerns the gene CD44 and cancer.